Cover Image

The Topical Nanodelivery of Vismodegib Enhances Its Skin Penetration and Performance <i>In Vitro</i> While Reducing Its Toxicity <i>In Vivo</i>

Vismodegib is a first-in-class inhibitor for advanced basal cell carcinoma treatment. Its daily oral doses present a high distribution volume and several side effects. We evaluated its skin penetration loaded in diverse nanosystems as potential strategies to reduce side effects and drug quantities....

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Natalia Calienni (Author), Daniela Maza Vega (Author), C. Facundo Temprana (Author), María Cecilia Izquierdo (Author), David E. Ybarra (Author), Ezequiel Bernabeu (Author), Marcela Moretton (Author), Fernando C. Alvira (Author), Diego Chiappetta (Author), Silvia del Valle Alonso (Author), María Jimena Prieto (Author), Jorge Montanari (Author)
Format: Book
Published: MDPI AG, 2021-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items